Stock Analysts’ updated eps estimates for Wednesday, October 11th:

Ardelyx (NASDAQ:ARDX) had its buy rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $12.00 target price on the stock.

Cascadian Therapeutics (NASDAQ:CASC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Cascadian Therapeutics, Inc. is a biopharmaceutical company specializing in developing innovative therapeutic product candidates for the treatment of cancer. The company’s product candidate is ONT-380, an orally active and selective small molecule HER2 inhibitor which is in preclinical trial stage. Cascadian Therapeutics, Inc., formerly known as Oncothyreon Inc., is headquartered in Seattle, Washington. “

Cathay General Bancorp (NASDAQ:CATY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $46.00 price target on the stock. According to Zacks, “Cathay General Bancorp is the one-bank holding company for Cathay Bank, a California state-chartered bank. Cathay Bank offers a wide range of financial services. Cathay Bank currently operates branches in California, New York State, Massachusetts, Houston, Texas, Washington State, and representative offices in Hong Kong and Shanghai, China. In addition, Cathay Bank’s subsidiaries, Cathay Investment Company and GBC Investment & Consulting Company, Inc., each maintain an office in Taipei. “

Codexis (NASDAQ:CDXS) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Codexis, Inc. is a leading protein engineering company that applies its technology to the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. Codexis’ proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. “

CECO Environmental Corp. (NASDAQ:CECE) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “CECO ENVIRONMENTAL CORP. manufactures and sells, primarily in the United States, of fiber bed mist eliminators to the chemical, printing, plating, power generation, food processing, waste incineration and textile industries. “

TCG BDC (NASDAQ:CGBD) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “TCG BDC, Inc. is an externally managed specialty finance company. It focused on providing flexible financing solutions to middle market companies primarily located in the United States. TCG BDC, Inc. is based in New York, United States. “

Community Healthcare Trust (NYSE:CHCT) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Community Healthcare Trust Incorporated is engaged in the acquisition of properties which are leased to hospitals, doctors, healthcare systems or other healthcare service providers. Community Healthcare Trust Incorporated is based in Franklin, United States. “

C&J Energy Services (NYSE:CJ) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “C&J Energy Services, Inc. is a provider of on-shore well construction, well completion, well support and other complementary oilfield services to oil and gas exploration and production companies. It offers hydraulic fracturing, cased-hole wireline, coiled tubing, cementing, rig services, fluids management services and other special well site services. The company operates primarily in United States and Western Canada. C&J Energy Services, Inc. is based in Houston, United States. “

Caladrius Biosciences (NASDAQ:CLBS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Caladrius Biosciences, Inc. is an immunotherapy company which specializes in cell process optimization, development and manufacturing. Its product candidate consists of NBS20, a targeted cancer immunotherapy product for the treatment of metastatic melanoma; NBS10, an ischemic repair product to preserve heart muscle function following an acute myocardial infarction and NBS03D, an immune modulation product for the treatment of diabetes which are in different clinical trials. Caladrius Biosciences, Inc., formerly known as NeoStem, Inc., is headquartered in New York. “

Mizuho started coverage on shares of Cloudera (NASDAQ:CLDR). Mizuho issued a neutral rating on the stock.

Crescent Point Energy Corporation (NYSE:CPG) (TSE:CPG) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “Crescent Point Energy Corp. is engaged in the acquisition, exploration and development of oil and natural gas properties in Western Canada. The Company’s operations consist of light and medium oil and natural gas assets strategically focused in core areas in southern Saskatchewan and central and southern Alberta. Crescent Point Energy Corp., formerly known as Crescent Point Energy Trust, is headquartered in Calgary, Canada. “

Consumer Portfolio Services (NASDAQ:CPSS) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “CONSUMER PORTFOLIO SERVICES is a consumer finance company that specializes in purchasing, selling, and servicing contracts with purchases of vechicles who are sub prime borrowers and are unable to obtain credit from traditional sources. “

Carlisle Companies (NYSE:CSL) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Carlisle Companies Incorporated engages in the manufacture and distribution of engineered products for both original equipment and aftermarket channels. The Company designs, manufactures and markets a range of products that serve a range of markets, including commercial roofing, energy, agriculture, mining, construction, aerospace and defense electronics, medical technology, transportation, general industrial, protective coatings, wood, auto refinishing, foodservice, and healthcare and sanitary maintenance. The Company operates through five segments: Carlisle Construction Materials (Construction Materials); Carlisle Interconnect Technologies (Interconnect Technologies); Carlisle Fluid Technologies; Carlisle Brake & Friction (Brake & Friction), and Carlisle FoodService Products. The Company markets its products as a component supplier to original equipment manufacturers and distributors, among others. Carlisle Companies Inc., markets its products to original equipment manufacturers and distributors. “

Capital Southwest Corporation (NASDAQ:CSWC) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Capital Southwest Corporation is a venture capital investment company whose objective is to achieve capital appreciation through long-term investments in businesses believed to have favorable growth potential. The Company’s investments are focused on early-stage financings, expansion financings, management buyouts and recapitalizations in a broad range of industry segments. The portfolio is a composite of companies in which the Company has major interests as well as a number of developing companies and marketable securities of established publicly-owned companies. “

CVB Financial Corporation (NASDAQ:CVBF) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “CVB Financial Corp. is a bank holding company. CVB’s principal business is to serve as a holding company for the Bank, Community, Ventures, and for other banking or banking related subsidiaries which the Company may establish or acquire. Through its network of banking offices, the Bank emphasizes personalized service combined with offering a full range of banking and trust services to businesses, professionals and individuals located in the service areas of its offices. “

Commercewest Bank Com (NASDAQ:CWBK) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “CommerceWest Bank provides a wide range of specialized commercial banking and financial services to entrepreneurs and small- to mid-sized businesses in southern California. Headquartered in Irvine, California, the company offers basic and analyzed checking accounts, money market accounts, saving accounts, certificates of deposit, attorney client services, and escrow accounts. The banks lending portfolio includes lines of credit; term loans; multifamily, construction, and commercial real estate loans; equipment financing; asset-based lines of credit; small business administration loans; state guaranteed programs; and letter of credit. It also offers online banking services, such as balance transfers, stop payments, make loan payments, and loan transfers. The company also offers various cash management services, signature services, and turnaround services. Regional offices are located throughout Southern California in Orange County, Inland Empire and Los Angeles. “

Tableau Software (NYSE:DATA) had its buy rating reissued by analysts at Barclays PLC. Barclays PLC currently has a $80.00 price target on the stock.

NOW (NYSE:DNOW) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “NOW Inc. is a distributor to the energy and industrial sectors. It stocks and sells a comprehensive offering of products for the upstream, midstream, and downstream & industrial market segments. The Company offers stock keeping units, including pipe, valves and valve automation, fittings, instrumentation, mill and industrial supplies, tools, safety supplies, electrical products, drilling and production equipment, fabricated equipment, and industrial paints and coatings. NOW also provides supply chain management solutions to energy and industrial manufacturing companies around the world. It operates primarily under the DistributionNOW and Wilson Export brands. NOW Inc. is headquartered in Houston, Texas. “

Dova Pharmaceuticals (NASDAQ:DOVA) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $31.00 price target on the stock. According to Zacks, “Dova Pharmaceuticals, Inc. is a pharmaceutical company. It focuses on acquiring, developing and commercializing drug candidates for thrombocytopenia diseases. The company’s drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist which are in clinical stage. Dova Pharmaceuticals, Inc. is based in Durham, North Carolina. “

Merck & (NYSE:MRK) was given a $70.00 price target by analysts at BMO Capital Markets. The firm currently has a buy rating on the stock.

Mazor Robotics (NASDAQ:MZOR) had its hold rating reissued by analysts at Barclays PLC. Barclays PLC currently has a $34.00 target price on the stock.

The Priceline Group (NASDAQ:PCLN) had its buy rating reissued by analysts at Barclays PLC. They currently have a $2,150.00 price target on the stock.

Receive News & Ratings for Ardelyx Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardelyx Inc and related companies with MarketBeat.com's FREE daily email newsletter.